Retrieve available abstracts of 15 articles: HTML format
Single Articles
September 2025
HOSAKA H, Kuribayashi S, Itoi Y, Sato K, et al The Role of Endoscopy in Gastroesophageal Reflux Disease.
Digestion. 2025 Sep 24:1-9. doi: 10.1159/000548088. PubMedAbstract available
INOUE H, Tanabe M, Yamamoto K, Nishikawa Y, et al Anti-reflux mucosal intervention for gastroesophageal reflux disease: a new
horizon of endoscopic anti-reflux therapy.
Digestion. 2025 Sep 15:1-22. doi: 10.1159/000547947. PubMedAbstract available
July 2025
HORIUCHI Y, Yamamoto N Characteristics of magnifying endoscopy with narrow-band imaging findings in
gastric cancer after Helicobacter pylori eradication.
Digestion. 2025 Jul 22:1-20. doi: 10.1159/000547574. PubMedAbstract available
June 2025
SHINOZAKI S, Sakamoto H, Osawa H, Yano T, et al Timing and Predictors for Vonoprazan Dose Escalation in Refractory
Gastroesophageal Reflux Disease: A Long-Term Observational Study.
Digestion. 2025 Jun 17:1-17. doi: 10.1159/000546992. PubMedAbstract available
March 2025
ABE H, Tarasawa K, Hatta W, Tanno N, et al Which of vonoprazan alone or intravenous proton pump inhibitor followed by
vonoprazan is optimal for reducing delayed bleeding in gastric endoscopic
submucosal dissection?
Digestion. 2025 Mar 25:1-19. doi: 10.1159/000545253. PubMedAbstract available
KUSANO C, Tsutsumi K, Horii T, Suzuki S, et al Is the Helicobacter pylori stool antigen test with the bioluminescent enzyme
immunoassay affected by proton pump inhibitors?
Digestion. 2025 Mar 21:1-19. doi: 10.1159/000545347. PubMedAbstract available
February 2025
BEN KHALED N, Schulz C, Alunni-Fabbroni M, Bronny K, et al Impact of Helicobacter pylori on Immune Checkpoint Inhibition in Hepatocellular
Carcinoma: A Multicenter Study.
Digestion. 2025 Feb 19:1-11. doi: 10.1159/000542847. PubMedAbstract available
December 2024
ISHIBASHI F, Suzuki S, Mochida K, Tonishi T, et al Cost-effectiveness analysis of endoscopic treatment versus medication strategy
for proton pump inhibitor-refractory gastroesophageal reflux disease.
Digestion. 2024 Dec 30:1-26. doi: 10.1159/000543365. PubMedAbstract available
September 2024
ISMAEL AT, Abdulhameed RA, Hamdi BA, Tawfeeq RD, et al C-Kit Immunohistochemical Expression as a Complementary Method to Assess Mast
Cell Density in Helicobacter Pylori-mediated Gastritis.
Digestion. 2024 Sep 13:1-22. doi: 10.1159/000541387. PubMedAbstract available
February 2024
UNO K, Shimura T, Inaguma S, Kuroyanagi K, et al Clinical impact of proton pump inhibitor and potassium-competitive acid blocker
for predicting the curability of endoscopic resection in ulcerative early gastric
cancer.
Digestion. 2024 Feb 2. doi: 10.1159/000536617. PubMedAbstract available
January 2024
HASHIGAMI K, Iwaya Y, Nagaya T, Hara D, et al Relationship between Helicobacter pylori eradication and Barrett's esophagus
elongation.
Digestion. 2024 Jan 30. doi: 10.1159/000536443. PubMedAbstract available
August 2023
OTA K, Takeuchi T, Higuchi K, Sasaki S, et al Frontiers in Endoscopic Treatment for Gastroesophageal Reflux Disease.
Digestion. 2023 Aug 17:1-6. doi: 10.1159/000533200. PubMedAbstract available
July 2023
HOSHIKAWA Y, Momma E, Kawami N, Iwakiri K, et al Lemborexant Attenuates Regurgitation without Worsening Objective Parameters on
Reflux Monitoring in Patients with Gastroesophageal Reflux Disease and Insomnia:
A Single-Arm Proof-of-Concept Study.
Digestion. 2023 Jul 10:1-8. doi: 10.1159/000531412. PubMedAbstract available
April 2023
ZHANG WL, Lin BS, Li YY, Ding YM, et al Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter
pylori Eradication: A Systematic Review and Meta-Analysis.
Digestion. 2023 Apr 4:1-13. doi: 10.1159/000529622. PubMedAbstract available
January 2023
MOMMA E, Koeda M, Hoshikawa Y, Tanabe T, et al Saliva Secretion Is Significantly Lower in Female Patients with Mild Reflux
Esophagitis than in Female Healthy Controls.
Digestion. 2023;104:299-305. PubMedAbstract available